Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M340Revenue $M26.5Net Margin (%)-132.6Z-Score2.6
Enterprise Value $M300EPS $-0.3Operating Margin %-132.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-132.5Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %-3.8Quick Ratio2.0Cash flow > EarningsY
Price/Sales12.75-y EBITDA Growth Rate %21.7Current Ratio2.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-43.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-62.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M132ROI % (ttm)-30.0Gross Margin Increase y-yY

Gurus Latest Trades with ATRS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ATRS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ATRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JACOB LEONARD SDirector 2015-03-23Sell23,500$2.68-3.73view
Fickenscher James ESenior Vice President & CFO 2014-12-11Buy40,000$2.53.2view
HOBBS EAMONN PPresident and CEO 2014-09-10Buy9,000$2.217.27view
ROCHE ROBERT P JRDirector 2014-08-13Buy5,000$1.9631.63view
JACOB LEONARD SDirector 2014-08-11Buy10,000$1.9830.3view
SAMSON MARVINDirector 2014-08-11Buy25,000$229view
GARRITY THOMAS JDirector 2014-08-11Buy5,000$1.9830.3view
GUETH ANTONDirector 2014-08-11Buy5,000$229view
JACOB LEONARD SDirector 2014-01-15Sell11,400$5.05-48.91view
Wotton Paul KPresident and CEO 2014-01-15Sell22,900$5.1-49.41view

Press Releases about ATRS :

    Quarterly/Annual Reports about ATRS:

    News about ATRS:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: ATRS, DENN, TTWO, JAH, ACET Jun 11 2013 

    More From Other Websites
    ANTARES PHARMA, INC. Financials Mar 18 2015
    Antares Pharma reports 4Q loss Mar 12 2015
    Antares Pharma reports 4Q loss Mar 12 2015
    Antares Pharma Reports Fourth Quarter and Full Year 2014 Operating and Financial Results Mar 12 2015
    ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 12 2015
    Q4 2014 Antares Pharma Inc Earnings Release - Before Market Open Mar 12 2015
    Antares Pharma Reports Fourth Quarter and Full Year 2014 Operating and Financial Results Mar 12 2015
    Antares Pharma To Host Fourth Quarter 2014 Operating and Financial Results Call Mar 06 2015
    Antares Pharma to Host Fourth Quarter 2014 Operating and Financial Results Conference Call Mar 05 2015
    Antares Pharma Announces Positive Topline Pharmakcokinetic Results From the Quickshot Phase 3 Study... Feb 25 2015
    ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 25 2015
    Antares' testosterone injection meets goal in late-stage study Feb 25 2015
    Antares Pharma Announces Positive Top-Line Pharmacokinetic Results from the QuickShot® Phase 3... Feb 25 2015
    Antares Pharma to Present at the Cowen and Company 35th Annual Healthcare Conference Feb 23 2015
    Antares Pharma to Present at the Cowen and Company 35Th Annual Healthcare Conference Feb 23 2015
    Antares Pharma to Present at the 2015 RBC Capital Markets Global Healthcare Conference Feb 18 2015
    Antares Pharma to Present at the 2015 RBC Capital Markets’ Global Healthcare Conference Feb 18 2015
    Antares Pharma Provides Regulatory Update on Sumatriptan Injection USP Jan 26 2015
    ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 26 2015
    Will Patterson Companies' Safety Measures Hold? - Analyst Blog Jan 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK